0000000001180402

AUTHOR

D S Chapman

showing 2 related works from this author

DOP41 Efficacy and safety of open-label treatment with tofacitinib 10 mg twice daily in patients with ulcerative colitis with clinical response, but …

2019

medicine.medical_specialtyTofacitinibOctave (poetry)business.industryOPEN LABEL TREATMENTGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisMaintenance therapyInternal medicinemedicineIn patientbusinessJournal of Crohn's and Colitis
researchProduct

Robustness of insect-flower networks to disturbance

2018

International audience

[SDE] Environmental Sciences[SDE]Environmental SciencesComputingMilieux_MISCELLANEOUS
researchProduct